S&P Futures
4,062.75 +58.00 (+1.45%) Dow Futures
32,519.00 +360.00 (+1.12%) Nasdaq Futures
12,473.75 +229.00 (+1.87%) Russell 2000 Futures
1,811.80 +29.40 (+1.65%) Crude Oil
114.17 -0.03 (-0.03%) Gold
1,830.10 +16.10 (+0.89%)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 0.1317 |
| Open | 0.1337 |
| Bid | 2.4100 x 2200 |
| Ask | 2.6500 x 3200 |
| Day's Range | 0.0881 - 0.1337 |
| 52 Week Range | 0.0881 - 1.4200 |
| Volume | |
| Avg. Volume | 31,048,831 |
| Market Cap | 44.861M |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2770 |
| Earnings Date | Mar 14, 2022 - Mar 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.70 |
- Motley Fool
Why Tonix Pharmaceuticals Stock Dived by Over 31% Today
All stocks have bad days at least once in a while, but Monday for Tonix Pharmaceuticals (NASDAQ: TNXP) was one of the ugliest trading sessions in its history. The company's stock lost nearly one-third of its value after the company announced a financial engineering move that sent investors scrambling for the exits. Tonix announced Monday afternoon that it is effecting a 1-for-32 reverse split of its common stock.
- GlobeNewswire
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
CHATHAM, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on May 17, 2022. The reverse stock split was previously approved by the Board of Directors of Tonix in accordance with Nevada law, under which no stockhold
- GlobeNewswire
New to The Street TV announces its 345th Episode, Airing Four Corporate Interviews, on the Fox Business Network, Tonight, Monday, May 16, 2022, at 10:30 PM PT
New to The Street TV announces its 345th Episode, Airing Four Corporate Interviews, on the Fox Business Network, Tonight, Monday, May 16, 2022, at 10:30 PM PT New to The Street’s 345th episode airs tonight, Monday, May 16, 2022, on the Fox Business Network, features the following four (4) Companies and their representatives:1). Tonix Pharmaceuticals, Inc.'s (NASDAQ: TNXP) interview with Dr. Seth Lederman, MD, CEO. 2). Sekur Private Data, Ltd.'s (fka -GlobeX Data, Ltd.) (OTCQX: SWISF) (CSE: SKUR)
